Cetera Investment Advisers’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
104,725
+9,617
| +10% | +$11.9K | ﹤0.01% | 3839 |
|
|
2025
Q1 | $112K | Buy |
95,108
+66,776
| +236% | +$78.8K | ﹤0.01% | 3749 |
|
|
2024
Q4 | $51.8K | Sell |
28,332
-91,167
| -76% | -$167K | ﹤0.01% | 3649 |
|
|
2024
Q3 | $203K | Buy |
119,499
+89,139
| +294% | +$152K | ﹤0.01% | 3372 |
|
|
2024
Q2 | $41.6K | Sell |
30,360
-11,157
| -27% | -$15.3K | ﹤0.01% | 3606 |
|
|
2024
Q1 | $156K | Buy |
41,517
+27,105
| +188% | +$102K | ﹤0.01% | 3417 |
|
|
2023
Q4 | $141K | Buy |
+14,412
| New | +$141K | ﹤0.01% | 2103 |
|